Ovarian Hyperstimulation Syndrome (OHSS) is a medical condition that can occur as a complication of fertility treatments, particularly in vitro fertilization (IVF). This syndrome develops when the ovaries respond excessively to hormonal medications used to stimulate egg production, leading to swollen and painful ovaries. While mild cases are relatively common and resolve on their own, severe OHSS can be a serious condition requiring immediate medical attention. Understanding the symptoms of OHSS is crucial for women undergoing fertility treatments, as early detection and proper management can prevent complications and ensure better outcomes.
OHSS occurs when the ovaries become overstimulated by fertility hormones, causing them to swell and leak fluid into the abdominal cavity. This condition typically develops within a week after egg retrieval or after ovulation induction. The severity of OHSS can range from mild discomfort to life-threatening complications, making it essential for patients and healthcare providers to monitor symptoms closely throughout the treatment process.
1. Abdominal Pain and Discomfort
One of the most prominent symptoms of OHSS is abdominal pain, which can range from mild discomfort to severe, debilitating pain. This pain results from the enlarged ovaries and the accumulation of fluid in the abdominal cavity. Women with OHSS often describe the sensation as a persistent ache or sharp, stabbing pain in the lower abdomen and pelvic region.
The pain may worsen with movement, physical activity, or changes in position. In mild cases, the discomfort might be similar to menstrual cramps or bloating. However, in moderate to severe cases, the pain can become intense enough to interfere with daily activities and may require pain management strategies. The abdominal area may also feel tender to the touch, and any pressure on the abdomen can intensify the discomfort.
It’s important to note that while some abdominal discomfort is expected after fertility treatments, persistent or worsening pain should always be reported to your healthcare provider, as it may indicate the development or progression of OHSS.
2. Severe Bloating and Abdominal Distension
Bloating and abdominal distension are hallmark symptoms of OHSS, often appearing more dramatic than typical bloating associated with menstruation or digestive issues. The abdomen may become noticeably swollen and tight, sometimes making it difficult to wear regular clothing comfortably. This bloating is caused by fluid accumulation in the abdominal cavity, a condition known as ascites.
Women with OHSS may notice that their abdomen appears significantly larger and feels firm or taut to the touch. The distension can develop rapidly, sometimes within 24 to 48 hours, and may be accompanied by a sensation of fullness or pressure. In severe cases, the abdomen may become so distended that it affects breathing and mobility.
The bloating associated with OHSS is typically more persistent than ordinary bloating and doesn’t improve with typical remedies like dietary changes or over-the-counter medications. The severity of abdominal distension often correlates with the severity of OHSS, making it an important indicator for healthcare providers when assessing the condition.
3. Rapid Weight Gain
Sudden and rapid weight gain is a significant warning sign of OHSS that should never be ignored. This weight increase is not due to fat accumulation but rather to fluid retention and accumulation in the body. Women with OHSS may gain several pounds within just a few days, with some cases reporting weight gains of 5 to 10 pounds or more in less than a week.
The rapid weight gain occurs because the overstimulated ovaries cause blood vessels to leak fluid into surrounding tissues and body cavities. This fluid retention can happen throughout the body but is most noticeable in the abdomen, where large amounts of fluid can accumulate. The weight gain may be accompanied by visible swelling in other areas of the body, such as the hands, feet, and legs.
Healthcare providers often recommend that women undergoing fertility treatments weigh themselves daily during the critical period after egg retrieval or ovulation induction. A sudden increase of more than 2 pounds per day or 5 pounds within a week should be reported immediately, as it may indicate developing or worsening OHSS requiring medical intervention.
4. Nausea and Vomiting
Nausea and vomiting are common gastrointestinal symptoms associated with OHSS, affecting many women who develop this condition. These symptoms can range from mild queasiness to severe, persistent vomiting that makes it difficult to keep food or fluids down. The nausea may be constant or come in waves, and it often worsens when the stomach is empty or after eating.
The gastrointestinal symptoms of OHSS occur due to several factors, including the hormonal changes associated with fertility treatments, the physical pressure of enlarged ovaries and fluid accumulation on the stomach and intestines, and the body’s inflammatory response to the condition. In some cases, the nausea may be severe enough to lead to dehydration, which can further complicate the condition.
Persistent vomiting is particularly concerning because it can prevent adequate fluid intake and lead to electrolyte imbalances. Women experiencing severe nausea and vomiting should contact their healthcare provider promptly, as they may need anti-nausea medication or intravenous fluids to maintain proper hydration. The inability to keep down liquids for more than 12 hours is considered a medical emergency and requires immediate attention.
5. Decreased Urination and Dark-Colored Urine
Changes in urination patterns are critical symptoms of OHSS that indicate the body’s fluid balance is being affected. Women with OHSS may notice that they are urinating less frequently than usual, producing smaller amounts of urine, or that their urine has become darker in color, resembling the color of tea or cola. These changes occur because fluid is shifting from the bloodstream into the abdominal cavity and other tissues, reducing the amount of fluid available for the kidneys to filter and excrete.
Decreased urine output, medically known as oliguria, is a sign that the body is becoming dehydrated despite overall fluid retention and swelling. The dark color of the urine indicates that it has become more concentrated due to reduced kidney function or dehydration. This symptom is particularly concerning because it suggests that the kidneys may be under stress and not functioning optimally.
Monitoring urine output and color is essential for women at risk of OHSS. Healthcare providers may ask patients to track their fluid intake and urine output during the critical period after fertility treatments. A significant decrease in urination (less than 500ml per day) or persistently dark urine despite adequate fluid intake warrants immediate medical evaluation, as these symptoms may indicate severe OHSS or kidney complications.
6. Shortness of Breath and Difficulty Breathing
Respiratory symptoms, including shortness of breath and difficulty breathing, are serious manifestations of moderate to severe OHSS. These symptoms can develop when fluid accumulates in the chest cavity (pleural effusion) or when severe abdominal distension restricts the movement of the diaphragm, the primary muscle involved in breathing. Women may feel breathless even during rest or minimal activity, and breathing may become labored or shallow.
The breathing difficulties associated with OHSS can range from mild breathlessness during physical exertion to severe respiratory distress requiring immediate medical attention. Some women may find it difficult to lie flat and may need to prop themselves up with pillows to breathe more comfortably. In severe cases, the reduced oxygen intake can lead to rapid heart rate, anxiety, and a sensation of not getting enough air.
Shortness of breath is always considered a warning sign that requires urgent medical evaluation, as it may indicate that OHSS is progressing to a severe stage. Respiratory symptoms can develop rapidly and may be accompanied by chest pain or tightness. Any woman experiencing significant breathing difficulties after fertility treatment should seek emergency medical care immediately, as this symptom can indicate life-threatening complications requiring hospitalization.
7. Swelling in the Legs and Hands
Peripheral edema, or swelling in the extremities, particularly the legs, ankles, feet, and hands, is another common symptom of OHSS. This swelling occurs due to the widespread fluid retention that characterizes the syndrome. The fluid leaks from blood vessels into surrounding tissues, causing visible puffiness and swelling. The swelling may be more pronounced at the end of the day or after prolonged standing or sitting.
Women with OHSS may notice that their shoes feel tighter, rings no longer fit comfortably, or there are visible indentations on their skin after removing tight clothing or pressing on the swollen areas. The skin over the swollen areas may appear stretched, shiny, or discolored. In some cases, the swelling can be accompanied by a sensation of heaviness or achiness in the affected limbs.
While mild swelling in the legs can be normal during certain times of the menstrual cycle or pregnancy, the edema associated with OHSS is typically more pronounced and develops rapidly. The swelling may be symmetrical, affecting both legs or both hands equally, and doesn’t improve significantly with rest or elevation of the limbs. Severe swelling, especially when accompanied by other OHSS symptoms, indicates significant fluid retention and requires medical assessment to prevent further complications.
Main Causes of Ovarian Hyperstimulation Syndrome
Understanding the causes of OHSS is essential for identifying who is at risk and implementing preventive strategies. The primary causes and risk factors include:
Fertility Medications: The main cause of OHSS is the use of injectable hormone medications, particularly human chorionic gonadotropin (hCG), used to stimulate ovulation and egg production during fertility treatments. These medications can cause the ovaries to produce multiple follicles and eggs, sometimes triggering an excessive response that leads to OHSS.
High Estrogen Levels: Elevated estrogen levels during fertility treatment cycles can increase the risk of developing OHSS. When multiple follicles develop in the ovaries, they produce large amounts of estrogen, which can contribute to increased vascular permeability and fluid leakage into body cavities.
Polycystic Ovary Syndrome (PCOS): Women with PCOS are at significantly higher risk of developing OHSS because their ovaries tend to be more sensitive to fertility medications and may produce a greater number of follicles in response to stimulation. The multiple small cysts characteristic of PCOS can amplify the ovarian response to hormonal stimulation.
Young Age and Low Body Weight: Younger women, particularly those under 35 years old, and women with a lower body mass index (BMI) are more susceptible to OHSS. These factors are associated with more responsive ovaries that may react more strongly to fertility medications.
Large Number of Follicles: The development of a high number of ovarian follicles during a stimulation cycle significantly increases the risk of OHSS. When ultrasound monitoring reveals many developing follicles or when blood tests show very high estradiol levels, the risk of OHSS is elevated.
Previous History of OHSS: Women who have experienced OHSS in a previous fertility treatment cycle are at increased risk of developing the condition again in subsequent cycles. This history helps healthcare providers identify high-risk patients and implement preventive measures.
Pregnancy: When pregnancy occurs following fertility treatment, the natural production of hCG by the developing embryo can worsen or prolong OHSS symptoms. This is why OHSS symptoms may persist longer or become more severe when the treatment cycle results in pregnancy.
Prevention Strategies for OHSS
While OHSS cannot always be prevented entirely, several strategies can significantly reduce the risk and severity of this condition:
Individualized Medication Protocols: Working with experienced fertility specialists who can tailor medication dosages to your individual characteristics is crucial. Lower doses of stimulation medications or alternative protocols may be recommended for women at higher risk of OHSS. Your doctor should carefully monitor your response throughout the treatment cycle and adjust medications accordingly.
Regular Monitoring: Frequent monitoring through blood tests and ultrasound examinations during fertility treatment cycles allows healthcare providers to assess the ovarian response and identify early signs of excessive stimulation. This close monitoring enables timely intervention before OHSS develops or becomes severe.
Coasting: If monitoring reveals a high risk of OHSS, your doctor may implement a “coasting” protocol, which involves withholding stimulation medications for a few days while continuing to monitor hormone levels. This allows estrogen levels to decrease while maintaining follicle maturation, reducing the risk of OHSS.
Triggering Alternatives: Instead of using hCG to trigger final egg maturation, some protocols use alternative medications that carry a lower risk of OHSS. Your fertility specialist can discuss whether these alternatives are appropriate for your situation.
Embryo Cryopreservation: For women at very high risk of OHSS, freezing all embryos and postponing transfer to a later cycle can be an effective prevention strategy. This approach eliminates the additional hCG stimulation that occurs with pregnancy, allowing the body to recover before attempting embryo transfer.
Adequate Hydration: Maintaining good hydration before, during, and after fertility treatments can help reduce the severity of OHSS symptoms. Drinking plenty of fluids, particularly those containing electrolytes, supports proper fluid balance and kidney function.
Protein Intake: Some evidence suggests that maintaining adequate protein intake may help reduce fluid shifts associated with OHSS. Your healthcare provider may recommend increasing protein consumption during and after fertility treatment cycles.
Activity Modification: Avoiding strenuous physical activity and heavy lifting during and after fertility treatments can help prevent ovarian torsion, a painful complication that can occur when enlarged ovaries twist on themselves.
Frequently Asked Questions
How soon after fertility treatment does OHSS develop?
OHSS typically develops within 3 to 10 days after egg retrieval or ovulation induction. Early-onset OHSS usually appears within a few days of the hCG trigger injection, while late-onset OHSS may develop 10 days or more after egg retrieval, particularly if pregnancy occurs.
Can OHSS occur naturally without fertility treatment?
While rare, spontaneous OHSS can occur without fertility medications, typically in women with polycystic ovary syndrome (PCOS) or those who are naturally pregnant with multiple fetuses. However, the vast majority of OHSS cases are related to fertility treatments.
How long does OHSS last?
Mild OHSS typically resolves within a few days to a week. Moderate cases may last one to two weeks. If pregnancy does not occur, symptoms usually improve with the onset of menstruation. However, if pregnancy occurs, OHSS symptoms may persist or worsen for several weeks as the body produces natural hCG.
Is OHSS dangerous or life-threatening?
Mild OHSS is uncomfortable but not dangerous. However, severe OHSS can lead to serious complications including blood clots, kidney failure, fluid accumulation in the lungs or chest cavity, ovarian torsion, and in very rare cases, death. This is why close monitoring and prompt medical attention for worsening symptoms are essential.
Can you still get pregnant if you have OHSS?
Yes, pregnancy can occur with OHSS, and in fact, pregnancy can make OHSS symptoms last longer or become more severe due to natural hCG production. Many women who develop OHSS do achieve successful pregnancies. In high-risk cases, doctors may recommend freezing embryos and postponing transfer to reduce OHSS risk.
What should I do if I suspect I have OHSS?
Contact your fertility clinic or healthcare provider immediately if you experience symptoms of OHSS, especially if you have severe abdominal pain, rapid weight gain, severe bloating, decreased urination, or difficulty breathing. Early intervention can prevent complications and improve outcomes. Do not wait to see if symptoms improve on their own, as OHSS can progress rapidly.
Who is most at risk for developing OHSS?
Women at highest risk include those with PCOS, women under 35 years old, those with low body weight, women with high numbers of developing follicles during stimulation, those with very high estrogen levels during treatment, and women who have had OHSS in previous cycles. Your fertility specialist should assess your individual risk factors before beginning treatment.
Can OHSS be prevented completely?
While OHSS cannot be prevented completely in all cases, careful monitoring, individualized medication protocols, and appropriate preventive strategies can significantly reduce both the risk and severity of OHSS. Modern fertility treatment protocols have greatly reduced the incidence of severe OHSS through improved monitoring and intervention techniques.
References:
- Mayo Clinic – Ovarian Hyperstimulation Syndrome
- Johns Hopkins Medicine – Ovarian Hyperstimulation Syndrome
- American College of Obstetricians and Gynecologists (ACOG)
- American Society for Reproductive Medicine – OHSS
- MedlinePlus – Ovarian Hyperstimulation Syndrome
The information on this page is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions related to your health.
Read the full Disclaimer here →